608 related articles for article (PubMed ID: 25223790)
21. Genome-Scale CRISPRa Screen Identifies Novel Factors for Cellular Reprogramming.
Yang J; Rajan SS; Friedrich MJ; Lan G; Zou X; Ponstingl H; Garyfallos DA; Liu P; Bradley A; Metzakopian E
Stem Cell Reports; 2019 Apr; 12(4):757-771. PubMed ID: 30905739
[TBL] [Abstract][Full Text] [Related]
22. A Cre-Dependent CRISPR/dCas9 System for Gene Expression Regulation in Neurons.
Carullo NVN; Hinds JE; Revanna JS; Tuscher JJ; Bauman AJ; Day JJ
eNeuro; 2021; 8(4):. PubMed ID: 34321217
[TBL] [Abstract][Full Text] [Related]
23. Robust Transcriptional Activation in Plants Using Multiplexed CRISPR-Act2.0 and mTALE-Act Systems.
Lowder LG; Zhou J; Zhang Y; Malzahn A; Zhong Z; Hsieh TF; Voytas DF; Zhang Y; Qi Y
Mol Plant; 2018 Feb; 11(2):245-256. PubMed ID: 29197638
[TBL] [Abstract][Full Text] [Related]
24. Cellular reprogramming with multigene activation by the delivery of CRISPR/dCas9 ribonucleoproteins via magnetic peptide-imprinted chitosan nanoparticles.
Lee MH; Lin CC; Thomas JL; Li JA; Lin HY
Mater Today Bio; 2021 Jan; 9():100091. PubMed ID: 33521619
[TBL] [Abstract][Full Text] [Related]
25. An Easy and Efficient Strategy for the Enhancement of Epothilone Production Mediated by TALE-TF and CRISPR/dcas9 Systems in
Ye W; Liu T; Zhu M; Zhang W; Huang Z; Li S; Li H; Kong Y; Chen Y
Front Bioeng Biotechnol; 2019; 7():334. PubMed ID: 32039165
[TBL] [Abstract][Full Text] [Related]
26. Generation of induced pluripotent stem cells (iPSCs) stably expressing CRISPR-based synergistic activation mediator (SAM).
Xiong K; Zhou Y; Hyttel P; Bolund L; Freude KK; Luo Y
Stem Cell Res; 2016 Nov; 17(3):665-669. PubMed ID: 27934604
[TBL] [Abstract][Full Text] [Related]
27. A genome-wide RNAi screen reveals determinants of human embryonic stem cell identity.
Chia NY; Chan YS; Feng B; Lu X; Orlov YL; Moreau D; Kumar P; Yang L; Jiang J; Lau MS; Huss M; Soh BS; Kraus P; Li P; Lufkin T; Lim B; Clarke ND; Bard F; Ng HH
Nature; 2010 Nov; 468(7321):316-20. PubMed ID: 20953172
[TBL] [Abstract][Full Text] [Related]
28. Stabilization of Foxp3 expression by CRISPR-dCas9-based epigenome editing in mouse primary T cells.
Okada M; Kanamori M; Someya K; Nakatsukasa H; Yoshimura A
Epigenetics Chromatin; 2017; 10():24. PubMed ID: 28503202
[TBL] [Abstract][Full Text] [Related]
29. CRISPR/Cas9 nuclease-mediated gene knock-in in bovine-induced pluripotent cells.
Heo YT; Quan X; Xu YN; Baek S; Choi H; Kim NH; Kim J
Stem Cells Dev; 2015 Feb; 24(3):393-402. PubMed ID: 25209165
[TBL] [Abstract][Full Text] [Related]
30. Transcriptional reprogramming and chromatin remodeling accompanies Oct4 and Nanog silencing in mouse trophoblast lineage.
Carey TS; Choi I; Wilson CA; Floer M; Knott JG
Stem Cells Dev; 2014 Feb; 23(3):219-29. PubMed ID: 24059348
[TBL] [Abstract][Full Text] [Related]
31. Targeted genome regulation and modification using transcription activator-like effectors.
Scott JN; Kupinski AP; Boyes J
FEBS J; 2014 Oct; 281(20):4583-97. PubMed ID: 25124066
[TBL] [Abstract][Full Text] [Related]
32. Engineering synthetic TALE and CRISPR/Cas9 transcription factors for regulating gene expression.
Kabadi AM; Gersbach CA
Methods; 2014 Sep; 69(2):188-97. PubMed ID: 25010559
[TBL] [Abstract][Full Text] [Related]
33. Multicolor CRISPR labeling of chromosomal loci in human cells.
Ma H; Naseri A; Reyes-Gutierrez P; Wolfe SA; Zhang S; Pederson T
Proc Natl Acad Sci U S A; 2015 Mar; 112(10):3002-7. PubMed ID: 25713381
[TBL] [Abstract][Full Text] [Related]
34. Hierarchical Oct4 Binding in Concert with Primed Epigenetic Rearrangements during Somatic Cell Reprogramming.
Chen J; Chen X; Li M; Liu X; Gao Y; Kou X; Zhao Y; Zheng W; Zhang X; Huo Y; Chen C; Wu Y; Wang H; Jiang C; Gao S
Cell Rep; 2016 Feb; 14(6):1540-1554. PubMed ID: 26832419
[TBL] [Abstract][Full Text] [Related]
35. TALE-mediated modulation of transcriptional enhancers in vivo.
Crocker J; Stern DL
Nat Methods; 2013 Aug; 10(8):762-7. PubMed ID: 23817068
[TBL] [Abstract][Full Text] [Related]
36. Designed Transcriptional Regulation in Mammalian Cells Based on TALE- and CRISPR/dCas9.
Lebar T; Jerala R
Methods Mol Biol; 2018; 1772():191-203. PubMed ID: 29754229
[TBL] [Abstract][Full Text] [Related]
37. Nac1 facilitates pluripotency gene activation for establishing somatic cell reprogramming.
Choi H; Park HJ; Kim H; Kim J; Lee YK; Kim J
Biochem Biophys Res Commun; 2019 Oct; 518(2):253-258. PubMed ID: 31412978
[TBL] [Abstract][Full Text] [Related]
38. Cas9 effector-mediated regulation of transcription and differentiation in human pluripotent stem cells.
Kearns NA; Genga RM; Enuameh MS; Garber M; Wolfe SA; Maehr R
Development; 2014 Jan; 141(1):219-23. PubMed ID: 24346702
[TBL] [Abstract][Full Text] [Related]
39. Generation of OCT4-EGFP, NANOG-tdTomato dual reporter human induced pluripotent stem cell line, KKUi001-A, using the CRISPR/Cas9 system.
Lee M; Choi NY; Park S; Bang JS; Lee Y; Jeong D; Ham S; Lim S; Kim KH; Ko K
Stem Cell Res; 2020 Oct; 48():101943. PubMed ID: 32777770
[TBL] [Abstract][Full Text] [Related]
40. OCT4 activity during conversion of human intermediately reprogrammed stem cells to iPSCs through mesenchymal-epithelial transition.
Teshigawara R; Hirano K; Nagata S; Ainscough J; Tada T
Development; 2016 Jan; 143(1):15-23. PubMed ID: 26657769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
